Seqster and La Jolla Institute of Immunology partner on asthma study

28th October 2019 (Last Updated October 28th, 2019 14:43)

Seqster has signed a three-year licensing deal and partnership with La Jolla Institute of Immunology (LJI) to support the execution of a $6.9m Asthma study.

Seqster has signed a three-year licensing deal and partnership with La Jolla Institute of Immunology (LJI) to support the execution of a $6.9m Asthma study.

The study is funded by the National Institutes of Health/National Heart, Lung and Blood Institute (NIH NHLBI), which establishes one of only ten PrecISE Network Clinical Centers across the country.

The Precision Interventions for Severe and/or Exacerbation-Prone Asthma (PrecISE) network aims to identify more effective treatments for patients identified with severe asthma.

Under the new collaboration, LJI will be able to access the Seqster Research Portal (SRP) technology that connects patients, clinicians and researchers to develop personalised treatments.

LJI chief operating officer and executive vice-president Stephen Wilson added: “We needed a scalable and robust platform that supports rapid person-centric data aggregation as well as real-time collection of longitudinal health records data to build this important and ambitious research cohort.

“The Seqster Research Portal is the only platform that will allow our PrecISE study participants to instantly collect and share medical records, genomic and device data with our researchers from anywhere in the country in a secure and transparent way while maintaining data ownership.”

The collaboration will also attempt to find a cure for asthma by analysing longitudinal data for a three-year period starting with 5,000 participants.

Seqster CEO and co-founder Ardy Arianpour said: “A commitment of this magnitude from such a prestigious research institute as LJI is further validation that Seqster’s person-centric approach to health data interoperability brings together patients, clinicians and researchers to accelerate discoveries, and we’re thrilled we can help support it.

“It is exciting that our SRP platform is providing the technology backbone for such an innovative clinical study infrastructure that will yield important efficacy and safety data on novel asthma interventions.”

In July this year, Boston University expanded their partnership to use Seqster’s Research Portal (SRP) solution that enables study participants to instantly collect and share medical records and device data with researchers.